139 related articles for article (PubMed ID: 10191120)
1. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
Pearce DA; Sherman F
Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
[TBL] [Abstract][Full Text] [Related]
2. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
Pearce DA; Ferea T; Nosel SA; Das B; Sherman F
Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861
[TBL] [Abstract][Full Text] [Related]
3. Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p.
Pearce DA; Nosel SA; Sherman F
Mol Genet Metab; 1999 Apr; 66(4):320-3. PubMed ID: 10191121
[TBL] [Abstract][Full Text] [Related]
4. A yeast model for the study of Batten disease.
Pearce DA; Sherman F
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6915-8. PubMed ID: 9618513
[TBL] [Abstract][Full Text] [Related]
5. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
Vitiello SP; Wolfe DM; Pearce DA
Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
[TBL] [Abstract][Full Text] [Related]
6. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.
Croopnick JB; Choi HC; Mueller DM
Biochem Biophys Res Commun; 1998 Sep; 250(2):335-41. PubMed ID: 9753630
[TBL] [Abstract][Full Text] [Related]
7. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
Gachet Y; Codlin S; Hyams JS; Mole SE
J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725
[TBL] [Abstract][Full Text] [Related]
8. BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase.
Pearce DA; Sherman F
Yeast; 1997 Jun; 13(8):691-7. PubMed ID: 9219333
[TBL] [Abstract][Full Text] [Related]
9. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic reversal of the btn1 defects in yeast by chloroquine: a yeast model for Batten disease.
Pearce DA; Carr CJ; Das B; Sherman F
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11341-5. PubMed ID: 10500178
[TBL] [Abstract][Full Text] [Related]
11. Defective lysosomal arginine transport in juvenile Batten disease.
Ramirez-Montealegre D; Pearce DA
Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
[TBL] [Abstract][Full Text] [Related]
12. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
Pearce DA
J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
[TBL] [Abstract][Full Text] [Related]
13. BTN1, the Saccharomyces cerevisiae homolog to the human Batten disease gene, is involved in phospholipid distribution.
Padilla-López S; Langager D; Chan CH; Pearce DA
Dis Model Mech; 2012 Mar; 5(2):191-9. PubMed ID: 22107873
[TBL] [Abstract][Full Text] [Related]
14. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.
Kim Y; Ramirez-Montealegre D; Pearce DA
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15458-62. PubMed ID: 14660799
[TBL] [Abstract][Full Text] [Related]
15. Batten disease: evaluation of CLN3 mutations on protein localization and function.
Haskell RE; Carr CJ; Pearce DA; Bennett MJ; Davidson BL
Hum Mol Genet; 2000 Mar; 9(5):735-44. PubMed ID: 10749980
[TBL] [Abstract][Full Text] [Related]
16. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
[TBL] [Abstract][Full Text] [Related]
17. Cross-species homology of the CLN3 gene.
Taschner PE; de Vos N; Breuning MH
Neuropediatrics; 1997 Feb; 28(1):18-20. PubMed ID: 9151313
[TBL] [Abstract][Full Text] [Related]
18. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
[TBL] [Abstract][Full Text] [Related]
19. The yeast model for batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis.
Chattopadhyay S; Muzaffar NE; Sherman F; Pearce DA
J Bacteriol; 2000 Nov; 182(22):6418-23. PubMed ID: 11053386
[TBL] [Abstract][Full Text] [Related]
20. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
